Published: 2022-06-16 15:07:18.855223Category:ScienceType:PhotoModel release: No
Share
Aducanumab, sold under the brand name Aduhelm, is a medication designed to treat Alzheimer's disease (AD). It is a monoclonal antibody that targets aggregated forms of amyloid beta found in the brains